Asylia was founded in 2019 to respond to the growing need for diagnostics solutions.
Asylia has set up a multi-disciplinary scientific team uniquely positioned to deliver precision medicine tools thanks to a combination of technical, biological, and laboratory skills acquired from over 40+ combined years of experience in research and leading biopharma companies. The team has further developed a specific technical background in the development of biomarker discovery, molecular biology, immunology, clinical sciences and AI building with direct applications to the field of oncology.
Dr. Yulia Mitina
Dr. Yulia Mitina, Head of Clinical Operations, is a seasoned MIT certified clinician with 5+ years of experience in leading the development of multiple clinical studies in the fields of molecular biology and immunology.